Clinical Trial

Alwide Plus China Post-market Clinical Investigation

Name: Alwide Plus China Post-market Clinical Investigation — clinical trial record (NCT07304427)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

This is a prospective, single-arm, multi-center, post-market registry study conducted in China. The purpose is to evaluate the safety and effectiveness of the AlwideTM Plus balloon catheter for pre-dilatation of the aortic valve during TAVR in the real-world setting.

Trial Details

NCT Number	NCT07304427
Lead Sponsor	Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Conditions	Severe Aortic Stenosis, Transcatheter Aortic Valve Replacemen
Enrollment	75 participants
Start Date	2025-01-03
Primary Completion	2025-10-11 (estimated)
Study Completion	2025-11-04 (estimated)
Updated on ClinicalTrials.gov	2025-12-26